Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF)
$ 28.6 0 (0%) Market Cap: 44.77 Bil Enterprise Value: 71.99 Bil PE Ratio: 23.21 PB Ratio: 0.98 GF Score: 78/100

Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Oct 31, 2019 / 08:45AM GMT
Release Date Price: $36

Oct 31, 2019 / 08:45AM GMT
Presentation
Oct 31, 2019 / 08:45AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Director
* Masato Iwasaki
Takeda Pharmaceutical Company Limited - President of Japan Pharma Business Unit & Director
* Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot